Showing results (281-290 of 592) with videos related to
Sort By:
Pageof 60
Annals of the Rheumatic Diseases|January 15, 2004
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritisS P McKenna, L C Doward, D Whalley, et al.Annals of the Rheumatic Diseases|August 16, 2005
Further evidence that a cartilage-pannus junction synovitis predilection is not a specific feature of rheumatoid arthritisL A Rhodes, P G Conaghan, A Radjenovic, et al.Rheumatology (Oxford, England)|September 29, 2007
A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritisA English, E A Jones, D Corscadden, et al.Journal of Medical Engineering & Technology|March 24, 2016
A novel low-profile ventriculoamniotic shunt for foetal aqueductal stenosisYanfei Chen, Stephen P Emery, Antonina P Maxey, et al.Nucleic Acids Research|June 20, 1998
DNA binding properties of a chemically synthesized DNA binding domain of hRFX1F Cornille, P Emery, W Schüler, et al.Best Practice & Research. Clinical Obstetrics & Gynaecology|August 6, 2025
Intervention or expectant management for stage I twin-twin transfusion syndromeRaphael Bartin, Nikan Zargarzadeh, Mohammadamin Parsaei, et al.Molecular and Cellular Biology|October 1, 1993
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerC A Siegrist, B Durand, P Emery, et al.BMJ (Clinical Research Ed.)|December 5, 1992
Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritisP Emery, M Salmon, H Bradley, et al.Annals of the Rheumatic Diseases|January 1, 1994
Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritisA K Gough, N F Peel, R Eastell, et al.Clinical and Experimental Immunology|October 1, 1991
Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?C Gordon, N Richards, A J Howie, et al.Pageof 60